Drug Development

Jennifer Markarian is a contributing editor for 

Articles

Polymeric containers offer an alternative to glass.

Considering Materials for Vaccine Containers

The funding will help advance the vaccine’s clinical evaluation, potential marketing authorization, development and manufacturing in Germany, and the number of participants in late-stage clinical trials.

BioNTech to Receive Funding from BMBF for its COVID-19 Vaccine Program

Vectura will support the product from Phase I through to commercial launch. 



Vectura and Monash University to Develop Inhaled Oxytocin for the Prevention of Postpartum Hemorrhage

Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.

AZD1222 Clinical Trials Resume in the UK

The investment at its Madison, WI, facility will expand MilliporeSigma’s capacity for high-potent active pharmaceutical ingredient production and allow for continuous flow manufacturing of ADCs.

MilliporeSigma Invests $65 Million to Expand Antibody-Drug Conjugate Manufacturing

The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.

Catalent Invests $130 Million to Expand Gene Therapy Manufacturing Capacity

The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes. 

Evonik Qualifies Filling Line for Parenteral Drug Products at its Alabama Facility 

AMRI will provide AstraZeneca with manufacturing capacity and sterile fill/finish services at its drug product manufacturing facility in Albuquerque, NM. 

AMRI Signs Agreement with AstraZeneca for COVID-19 Vaccine Delivery

The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.

AstraZeneca Pauses Clinical Trial on COVID-19 Vaccine for Safety Review

As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.

Formulation and Drug Delivery